On Friday, ProMIS Neurosciences Inc (NASDAQ: PMN) was 2.74% up from the session before settling in for the closing price of $0.53. A 52-week range for PMN has been $0.38 – $1.59.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -824.96%. With a float of $15.64 million, this company’s outstanding shares have now reached $32.69 million.
ProMIS Neurosciences Inc (PMN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ProMIS Neurosciences Inc stocks. The insider ownership of ProMIS Neurosciences Inc is 52.15%, while institutional ownership is 21.86%. The most recent insider transaction that took place on Feb 10 ’25, was worth 14,595. In this transaction Chief Scientific Officer of this company bought 15,000 shares at a rate of $0.97, taking the stock ownership to the 16,617 shares. Before that another transaction happened on Sep 24 ’24, when Company’s Director bought 70,000 for $1.30, making the entire transaction worth $91,028. This insider now owns 208,333 shares in total.
ProMIS Neurosciences Inc (PMN) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.43 earnings per share (EPS) during the time that was better than consensus figure (set at -0.1) by 0.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -824.96% per share during the next fiscal year.
ProMIS Neurosciences Inc (NASDAQ: PMN) Trading Performance Indicators
You can see what ProMIS Neurosciences Inc (PMN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of ProMIS Neurosciences Inc (PMN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.27 million. That was inferior than the volume of 2.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.67%.
During the past 100 days, ProMIS Neurosciences Inc’s (PMN) raw stochastic average was set at 13.21%, which indicates a significant decrease from 15.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0490 in the past 14 days, which was lower than the 0.0794 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5947, while its 200-day Moving Average is $0.7213. However, in the short run, ProMIS Neurosciences Inc’s stock first resistance to watch stands at $0.5508. Second resistance stands at $0.5617. The third major resistance level sits at $0.5746. If the price goes on to break the first support level at $0.5270, it is likely to go to the next support level at $0.5141. Assuming the price breaks the second support level, the third support level stands at $0.5032.
ProMIS Neurosciences Inc (NASDAQ: PMN) Key Stats
There are 51,806K outstanding shares of the company, which has a market capitalization of 27.97 million. As of now, sales total 0 K while income totals 2,780 K. Its latest quarter income was 0 K while its last quarter net income were -10,120 K.
